ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,064Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 117

$550K Total Retail Price of All Prescriptions

Rank: 39 out of 117

292 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 292 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

23% of this provider’s 292 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 8,013 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
NAMENDA 464 464 1 7
LEVOTHYROXINE SODIUM 409 401 2 1
HYDROCODONE-ACETAMINOPHEN 349 342 S3 3 3
DONEPEZIL HCL 314 314 4 10
AMLODIPINE BESYLATE 252 251 5 5
OMEPRAZOLE 249 249 6 9
FUROSEMIDE 239 239 7 4
ESCITALOPRAM OXALATE 184 181 8 29
QUETIAPINE FUMARATE 180 180 9 20
MIRTAZAPINE 160 160 10 14
SIMVASTATIN 158 150 11 2
LISINOPRIL 139 139 12 6
CITALOPRAM HBR 134 134 13 18
SERTRALINE HCL 134 134 13 16
METOPROLOL SUCCINATE 120 120 15 17
TRAMADOL HCL 114 114 16 19
EXELON 86 86 17 34
METOPROLOL TARTRATE 85 85 18 8
ATORVASTATIN CALCIUM 83 83 19 21
ISOSORBIDE MONONITRATE ER 82 82 20 48
LEXAPRO 81 80 21 86
ZOLPIDEM TARTRATE 79 79 22 24
POTASSIUM CHLORIDE 77 77 23 11
SEROQUEL 74 74 24 57
LOSARTAN POTASSIUM 67 67 25 32
LIDODERM 66 66 26 62
DIOVAN 66 66 26 38
VENLAFAXINE HCL ER 65 65 28 78
GABAPENTIN 63 63 29 12
TAMSULOSIN HCL 60 60 30 31
TRAZODONE HCL 58 58 31 23
ALENDRONATE SODIUM 58 58 31 26
NEXIUM 57 57 33 36
CARVEDILOL 55 55 34 22
HYDROCHLOROTHIAZIDE 54 54 35 28
FORTICAL 52 52 36 219
METFORMIN HCL 52 52 36 15
JANTOVEN 51 51 38 120
RAMIPRIL 50 50 39 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 6, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.